Skip to content
Aperlena
Free alerts

TED - Tenders Electronic Daily (Publications Office of the EU) verified 6 days ago Contract notice

Germany - Medicines - Discount agreements pursuant to Section 130a paragraph 8 SGB V under open-house procedures

Original Deutschland - Arzneimittel - Arzneimittelrabattverträge gem. § 130a Abs. 8 SGB V im Rahmen von Open-House-Verfahren

Open Germany Dresden Medical equipment & pharmaceuticals

Buyer IKK classic

270 days left

Key facts

Closes
23:59 (UTC+2)
Procedure
Open procedure
  1. Published
  2. Today
  3. Deadline open for 686 days
  4. Awarded pending
View the official notice Watch this tender
Add to calendar

If the deadline moves or the notice is corrected, we email you. Log in

Summary

Machine-generated summary

IKK classic announces that it will conclude non-exclusive rebate agreements with all interested and suitable pharmaceutical companies for various active ingredients and active ingredient combinations under the same non-negotiable conditions, pursuant to Section 130a paragraph 8 SGB V. The agreement period runs from 1 September 2025 to 31 August 2027, with the Omalizumab lot starting 1 October 2025. The earliest contract start is 1 September 2025 if signed contracts and all required documents reach IKK classic by 5 August 2025. Joining is possible at any time until 5 July 2027. Substances covered include Abatacept, Atovaquone, Beclometasone and Formoterol, Betaine, Brinzolamide and Brimonidine, Certolizumab pegol, Colesevelam, Etravirine, immunoglobulins and Melatonin.

Key points

Die IKK classic gibt hiermit bekannt, dass sie mit allen interessierten und geeigneten pharmazeutischen Unternehmen im Zeitraum vom 01.09.2025 bis zum 31.08.2027 (abweichend Los Omalizumab 01.10.2025) zu verschiedenen Wirkstoffen und Wirkstoffkombinationen nicht-exklusive Rabattvereinbarungen nach § 130a Abs. 8 SGB V zu gleichen, nicht verhandelbaren Bedingungen abschließen wird. Frühester Vertragsbeginn ist der 01.09.2025, sofern der unterschriebene Vertrag und alle nötigen Nachweise, Eigenerklärungen und Unterlagen bis zum 05.08.2025 bei der IKK classic eingehen. Für das Los Omalizumab ist der früheste Vertragsbeginn der 01.10.2025, sofern die Unterlagen bis zum 10.09.2025 bei der IKK classic eingehen. Danach gilt: Bei Eingang der Unterlagen bis zum 05. eines jeweiligen Monats im möglichen Beitrittszeitraum wird der jeweils 01. des Folgemonats Vertragsbeginn. Bei Eingang der Unterlagen nach dem 05. eines jeweiligen Monats im möglichen Beitrittszeitraum wird der jeweils 01. des übernächsten Folgemonats Vertragsbeginn. Ein Beitritt zur Vereinbarung ist im angegebenen Zeitraum jederzeit möglich, spätestens jedoch bis zum 05.07.2027. Weitere Angaben siehe Pkt. VI.3). Abatacept ATC-Code: L04AA24; Atovaquon ATC-Code: P01AX06; Beclometason und Formoterol; Dosieraerosol; 100/6µg ATC-Code: R03AK08; Beclometason und Formoterol; Dosieraerosol 200/6µg ATC-Code: R03AK08; Beclometason und Formoterol; Inhalationspulver, Inhalat ATC-Code: R03AK08; Betain ATC-Code: A16AA06; Brinzolamid und Brimonidin ATC-Code: S01EC24 (ADV); S01EC54 (WHO); Certolizumabpegol ATC-Code: L04AB05; Colesevelam ATC-Code: C10AC04; Etravirin ATC-Code: J05AG04; Immunglobuline intravasal ATC-Code: J06BA02; Immunglobuline, normal human, zur extravasalen Anwendung ATC-Code: J06BA01; Melatonin, 1 mg oder 5 mg pro Retardtablette Indikation: Behandlung von Schlafstörungen (Insomnie) bei Kindern und Jugendlichen im Alter von 2-18 Jahren mit Autismus-Spektrum-Störung (ASS) und/oder Smith-Magenis-Syndrom, wenn Schlafhygienemaßnahmen unzureichend waren. ATC-Code: N05CH01; Omalizumab ATC-Code: R03DX05; Palonosetron; Weichkapseln ATC-Code: A04AA05; Ponesimod ATC-Code: L04AE04; Relugolix ATC-Code: L02BX04; Sumatriptan, Injektionslösung, Injektionslösung in einem Fertigpen, Nasenspray ATC-Code: N02CC01; Tacrolimus 0,03 % Salbe ATC-Code: D11AH01; Tiotropiumbromid; Inhalationslösung ATC-Code: R03BB04; Trifluridin, Kombinationen ATC-Code: L01BC59; Eltrombopag ATC-Code: B02BX05; Dexamethason; Implantat ATC-Code: S01BA01
Original text
Die IKK classic gibt hiermit bekannt, dass sie mit allen interessierten und geeigneten pharmazeutischen Unternehmen im Zeitraum vom 01.09.2025 bis zum 31.08.2027 (abweichend Los Omalizumab 01.10.2025) zu verschiedenen Wirkstoffen und Wirkstoffkombinationen nicht-exklusive Rabattvereinbarungen nach § 130a Abs. 8 SGB V zu gleichen, nicht verhandelbaren Bedingungen abschließen wird. Frühester Vertragsbeginn ist der 01.09.2025, sofern der unterschriebene Vertrag und alle nötigen Nachweise, Eigenerklärungen und Unterlagen bis zum 05.08.2025 bei der IKK classic eingehen. Für das Los Omalizumab ist der früheste Vertragsbeginn der 01.10.2025, sofern die Unterlagen bis zum 10.09.2025 bei der IKK classic eingehen. Danach gilt: Bei Eingang der Unterlagen bis zum 05. eines jeweiligen Monats im möglichen Beitrittszeitraum wird der jeweils 01. des Folgemonats Vertragsbeginn. Bei Eingang der Unterlagen nach dem 05. eines jeweiligen Monats im möglichen Beitrittszeitraum wird der jeweils 01. des übernächsten Folgemonats Vertragsbeginn. Ein Beitritt zur Vereinbarung ist im angegebenen Zeitraum jederzeit möglich, spätestens jedoch bis zum 05.07.2027. Weitere Angaben siehe Pkt. VI.3). Abatacept; ATC-Code: L04AA24; Atovaquon; ATC-Code: P01AX06; Beclometason und Formoterol; Dosieraerosol; 100/6µg; ATC-Code: R03AK08; Beclometason und Formoterol; Dosieraerosol 200/6µg; ATC-Code: R03AK08; Beclometason und Formoterol; Inhalationspulver, Inhalat; ATC-Code: R03AK08; Betain; ATC-Code: A16AA06; Brinzolamid und Brimonidin; ATC-Code: S01EC24 (ADV); S01EC54 (WHO); Certolizumabpegol; ATC-Code: L04AB05; Colesevelam; ATC-Code: C10AC04; Etravirin; ATC-Code: J05AG04; Immunglobuline intravasal; ATC-Code: J06BA02; Immunglobuline, normal human, zur extravasalen Anwendung; ATC-Code: J06BA01; Melatonin, 1 mg oder 5 mg pro Retardtablette; Indikation: Behandlung von Schlafstörungen (Insomnie) bei Kindern und Jugendlichen im Alter von 2-18 Jahren mit Autismus-Spektrum-Störung (ASS) und/oder Smith-Magenis-Syndrom, wenn Schlafhygienemaßnahmen unzureichend waren.; ATC-Code: N05CH01; Omalizumab; ATC-Code: R03DX05; Palonosetron; Weichkapseln; ATC-Code: A04AA05; Ponesimod; ATC-Code: L04AE04; Relugolix; ATC-Code: L02BX04; Sumatriptan, Injektionslösung, Injektionslösung in einem Fertigpen, Nasenspray; ATC-Code: N02CC01; Tacrolimus 0,03 % Salbe; ATC-Code: D11AH01; Tiotropiumbromid; Inhalationslösung; ATC-Code: R03BB04; Trifluridin, Kombinationen; ATC-Code: L01BC59; Eltrombopag; ATC-Code: B02BX05; Dexamethason; Implantat; ATC-Code: S01BA01

Bid or no-bid?

Six questions before you commit a team. Under each one, what the register holds on it. The answers are yours.

  1. In your favour:

    Do we meet every eligibility criterion?

    Open procedure: any interested supplier may submit a bid.

    Above the EU threshold: open to companies from any EU country.

  2. Your call:

    Can we deliver this with the team we have?

    The register holds nothing on this. The official documents will.

  3. Your call:

    Do we have two comparable references?

    Comparable work is in Medical equipment & pharmaceuticals.

  4. In your favour:

    Is the deadline realistic for a proper offer?

    270 days left, 192 of them working days.

  5. Your call:

    Is there a margin at the likely winning price?

    In this country this kind of contract is usually awarded for between €215,780 and €1.0M.

  6. Your call:

    Do we know this buyer?

    The register holds nothing on this. The official documents will.

Can I bid?

  • Open procedure: any interested supplier may submit a bid. Above the EU threshold: open to companies from any EU country.
  • The notice is written in German.
  • Certificates from another EU country? Check the equivalents on eCertis

Official source

Source: TED - Tenders Electronic Daily (Publications Office of the EU)

Always verify details on the official notice.

Report an error in this notice

Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 6 days ago

View the official notice

What this market pays

The buyer has too few awards of its own in this sector, so this is the range of the last 313 awards for Medical equipment & pharmaceuticals in Germany.

Median award
€377,000
Middle half of past awards
€215,780 to €1.0M

TED - Tenders Electronic Daily (Publications Office of the EU) publishes no value for this notice, so it has no mark on the scale. The official documents may state one.

Award values as published by the official sources. Use them as a guide, not a rule: scope, lots and duration differ between contracts.

The buyer

Full buyer profile

IKK classic

Germany

Who wins its contracts

Many suppliers
different companies won its awards
52
of the awards went to the three most frequent winners
12%
of its calls state an estimated value
5%

Based on 57 awards with a named winner over the last 3 years. Counted by award, not by value, because lot and framework amounts are not comparable. Concentrated means the three most frequent winners took 65% or more of the awards; many suppliers, under 35% with at least ten different winners.

Competition

tenders per lot on average (open and restricted procedures)
4.4
of those lots received a single tender
13%
of the awards went to companies based in another country
12%

As the official award notices state them, over the last 3 years. Tenders per lot count open and restricted procedures only: in a negotiated procedure or a direct award a single tender is the procedure itself. The country is the one the notice gives for the winner.

This buyer has no award history in this sector yet. Usual winners, Medical equipment & pharmaceuticals - Germany

Company Wins Total awarded Last win
Siemens Healthineers AG 86 €30.9M Oct 2026
Philips GmbH 31 €9.0M Sep 2026
Brainlab Sales GmbH 21 €8.5M Sep 2026
Intuitive Surgical Deutschland GmbH 16 €22.7M Sep 2026
Philips GmbH Market DACH 16 €8.0M Jul 2026

Based on 1521 awards with a linked company profile over the last 2 years.

18 open tenders right now

Market context

TED - Tenders Electronic Daily (Publications Office of the EU) publishes no value for this notice, so it cannot be placed among the open notices of its sector. The official documents may state one.

open now in Medical equipment & pharmaceuticals
11,064
median open notice
€140,000

Who wins in this market

Many suppliers

Germany · Medical equipment & pharmaceuticals

different companies won awards here
814
of the awards went to the three most frequent winners
9%
buyers awarded contracts here
445

Based on 1,521 awards with a named winner over the last 3 years. Counted by award, not by value, because lot and framework amounts are not comparable. Concentrated means the three most frequent winners took 65% or more of the awards; many suppliers, under 35% with at least ten different winners.

Competition

tenders per lot on average (open and restricted procedures)
12.2
of those lots received a single tender
16%
of the awards went to companies based in another country
7%
of the tenders came from another country
6%

As the official award notices state them, over the last 3 years. Tenders per lot count open and restricted procedures only: in a negotiated procedure or a direct award a single tender is the procedure itself. The country is the one the notice gives for the winner.

Similar tenders

Open now

Awarded before

Never miss a tender like this

62 new notices in Medical equipment & pharmaceuticals in Germany in the last 7 days. Get an email when new ones appear. Free.

Set up my alert

270 days left

Open notice

Keyboard shortcuts

Read a list without reaching for the mouse. The shortcuts stay quiet while you type in a field.

j
Next result
k
Previous result
Enter
Open the result
n
Next page
p
Previous page
c
Compare this result
s
Shortlist this result
o
Open the result in a new tab
x
Set this result aside
/
Search from any page
Ctrl K
Search from any page
?
Show these shortcuts
Esc
Close

Start from a question

Browse by sector

Index

Close
Log in

Language